Skip to main content
Clinical Trials/EUCTR2013-001737-40-BE
EUCTR2013-001737-40-BEActive, not recruitingPhase 1

Effect of curcumin addition to standard treatment on tumour-induced inflammation in endometrial carcinoma - Curcumun-2013

Z Leuven0 sites0 target enrollmentStarted: June 4, 2013Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • Endometrial carcinoma, histologically confirmed
  • No life-threatening metastases
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 5
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

Exclusion Criteria

  • Other active malignancy
  • Documented autoimmune disease
  • Currently ongoing immunosuppressive therapy
  • Simultaneous treatment according to other clinical trials
  • Documented immune deficiency

Investigators

Sponsor
Z Leuven

Similar Trials